This federal contract award to Edwards Lifesciences LLC, a self-certified small disadvantaged business and limited liability company subsidiary of Edwards Lifesciences Corporation, is for the provision of Transcatheter Aortic Valve Replacement (TAVR) products and services to the U.S. Department of Veterans Affairs (VA) and Veterans Health Administration (VHA). The $34,000.00 firm fixed-price purchase order contract has a completion date of March 26, 2025 and was awarded on February 24, 2025 by the VA's Veterans Integrated Service Network 23. The contract is not associated with any set-aside designation.
Edwards Lifesciences LLC has received numerous prime contract awards from the VA and VHA to provide specialized cardiovascular devices and related services, including heart valves, surgical implants, and transcatheter aortic valve replacement kits and procedures. This award appears to be one of many supporting the VA's healthcare services for veterans across various Veterans Integrated Service Networks nationwide.
Generated 2/25/25, 10:10 AM